A 68-Year-Old Woman With Stage IV Ovarian Cancer

Video

Ramez Eskander, MD, presents the case of a 68-year-old woman with stage IV ovarian cancer, and discusses the management approach for this patient and similar cases.

Case Overview:

Initial Presentation

  • A 68-year-old postmenopausal woman presented with fatigue, urinary frequency, early satiety, abdominal bloating and distention
  • PMH: HTN, medically treated with lisinopril
  • SH: retired; grandmother of 3; never-smoker; social alcohol use
  • PE: abdominal distention, bloating, and a positive fluid wave test; otherwise unremarkable


Clinical work-up

  • Pelvic exam with transvaginal ultrasound showed a right ovarian mass
  • Chest/abdomen/pelvis CT with contrast revealed a right adnexal 5.3-cm complex mass, a suspicious intraparenchymal liver lesion, retroperitoneal lymph node enlargement and concurrent pleural effusion
  • Lymph node and adnexal mass biopsy confirmed high-grade, epithelial ovarian cancer; positive cytology of pleural effusion
    • T1N1M1
  • Germline molecular testing showed BRCA1/2 wild-type, HRD+
  • CA-125, 438 U/mL
  • ECOG: 1

Treatment

  • Patient underwent TAH/BSO, lymph node dissection, with suboptimal debulking; residual disease 1.3 cm
  • Paclitaxel/carboplatin/bevacizumab + maintenance bevacizumab
    • After 3 cycles, patient underwent second debulking surgery, R0
  • Continued on bevacizumab for 6 more cycles
    • Achieved partial response, post treatment CA-125, 40 U/mL
       

Follow-up

  • At 3 months
    • CA-125, 18 U/mL
    • Chest/abdomen/pelvis CT showed no gross pelvic masses or nodes
    • Pelvic exam was unremarkable
Related Videos
Video 8 - "Clinical Pearls for Optimal Management of mHSPC"
Video 7 - "Multidisciplinary Approach in mHSPC Management "
Video 6 - "Treatment Considerations in High Disease Burden and Comorbidities"
Video 5 - "Pivotal Trials in mHSPC"
Video 4 - "ARASENS Trial- Darolutamide in mHSPC"
Video 3 - "Treatment Intensification in Metastatic Prostate Cancer"
Video 2 - "Treatment Options for mHSPC"
Video 1 - "Initial Impression and Risk Assessment"
Yi-Bin Chen, MD, an expert on GVHD
Yi-Bin Chen, MD, an expert on GVHD
Related Content